ArticlePharmaceutics2026
Diluted Etilefrine for Neonatal Chylothorax: A 96-Hour Physicochemical Stability Study.
Louisa Bourel, Sixtine Gilliot, Zeina Boulos, Yousra Alouadni, Kévin Le Duc, Mohamed Riadh Boukhris, Laurent Storme, Anthony Martin Mena, Pascal Odou
Abstract read
In one paragraphArticle in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Louisa BourelCHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, University Lille, F-59000 Lille, France.ORCID 0000-0002-1821-6171 Sixtine GilliotCHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, University Lille, F-59000 Lille, France.
Zeina BoulosCHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, University Lille, F-59000 Lille, France.
Yousra AlouadniCHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, University Lille, F-59000 Lille, France.
Kévin Le DucCHU Lille, ULR 2694 METRICS: Evaluation des Technologies de Santé et des Pratiques Médicales-Perinatal Environment and Health, University Lille, F-59000 Lille, France.ORCID 0000-0003-4970-4458 Mohamed Riadh BoukhrisCHU Lille, Department of Neonatology, Jeanne de Flandre Hospital, F-59000 Lille, France.
Laurent StormeCHU Lille, ULR 2694 METRICS: Evaluation des Technologies de Santé et des Pratiques Médicales-Perinatal Environment and Health, University Lille, F-59000 Lille, France.
Anthony Martin MenaCHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, University Lille, F-59000 Lille, France.ORCID 0000-0002-0089-5284 Pascal OdouCHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, University Lille, F-59000 Lille, France.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
chylothoraxdrug stabilityetilefrineneonatal intensive care
Identifiers
PMID42797310
PMCPMC13610745
What OpenQuestion holds
Textmetadata
Read underepoch 390